WARSAW, Ind., Aug. 26, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a worldwide medical expertise chief, as we speak introduced that its Board of Administrators has accredited the fee of a quarterly money dividend to stockholders for the third quarter of 2022. The money dividend of $0.24 per share is payable on or about October 31, 2022 to stockholders of report as of the shut of enterprise on September 30, 2022.

Concerning the Firm
Zimmer Biomet is a worldwide medical expertise chief with a complete portfolio designed to maximise mobility and enhance well being. We seamlessly remodel the affected person expertise by way of our modern merchandise and suite of built-in digital and robotic applied sciences that leverage knowledge, knowledge analytics and synthetic intelligence.  

With 90+ years of trusted management and confirmed experience, Zimmer Biomet is positioned to ship the best high quality options to sufferers and suppliers. Our legacy continues to return to life as we speak by way of our progressive tradition of evolution and innovation. 

For extra details about our product portfolio, our operations in 25+ nations and gross sales in 100+ nations or about becoming a member of our crew, go to www.zimmerbiomet.com or observe Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Media                                                                              Traders
Meredith Weissman                                                      Keri Mattox
703-346-3127                                                                215-275-2431
[email protected]                 [email protected] 

SOURCE Zimmer Biomet Holdings, Inc.



Supply hyperlink

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Interspinous Spacers Market Dimension to Develop by USD 18.52 Million, Rising Prevalence of Spinal Issues to Drive Development

Interspinous Spacers Market Dimension to Develop by USD 18.52 Million, Rising Prevalence of Spinal Issues to Drive Development

NEW YORK, Sept. 3, 2022 /PRNewswire/ — The interspinous spacers market will likely be pushed by components such because the rising prevalence of spinal problems. The aged inhabitants is susceptible

Platelet-rich Plasma (PRP) Remedy in Lateral Epicondylitis Market Share, By Product Evaluation, Software, Finish-Use, Regional Outlook, Aggressive Methods & Forecast as much as 2028

Platelet-rich Plasma (PRP) Remedy in Lateral Epicondylitis Market Share, By Product Evaluation, Software, Finish-Use, Regional Outlook, Aggressive Methods & Forecast as much as 2028

The Platelet-rich Plasma (PRP) Remedy in Lateral Epicondylitis market analysis doc features a thorough examination of the important thing developments which can be anticipated to form the

Zimmer Biomet, Surgical Planning associate on whole hip alternative

Zimmer Biomet, Surgical Planning associate on whole hip alternative

[Image from Surgical Planning] Zimmer Biomet (NYSE:ZBH) introduced at present that it signed an unique, multi-year co-marketing settlement with Surgical Planning. Warsaw, Indiana-based ZB’s settlement with Surgical Planning Associates across